- Report
- October 2024
- 180 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- October 2024
- 198 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- March 2025
- 187 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- October 2024
- 191 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 273 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 278 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 602 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- April 2025
- 194 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- April 2025
- 193 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- April 2025
- 194 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- April 2025
- 432 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 89 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 92 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 487 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 226 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- April 2025
- 194 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- April 2025
- 194 Pages
Global
From €4692EUR$4,950USD£3,920GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more